Company Name: KOBAY TECHNOLOGY BERHAD
Stock Name: KOBAY
Date Announced: 05 Jul 2021
Category: Document Submission
Reference Number: DCS-01072021-00016
Subject: CIRCULAR TO SHAREHOLDERS IN RELATION TO THE (I) PROPOSED ACQUISITION BY KOBAY TECHNOLOGY BHD (“KOBAY” OR “COMPANY”) OF 70% EQUITY INTEREST IN (A) AVELON HEALTHCARE SDN BHD, (B) GALAXIS HEALTHCARE SDN BHD, (C) AVELON ARISE SDN BHD, (D) GALAXIS PHARMA SDN BHD AND (E) ARISE HEALTHCARE SDN BHD (COLLECTIVELY REFERRED TO AS THE “AVELON GROUP”) FROM THE VENDORS (AS DEFINED HEREIN) FOR A TOTAL CASH CONSIDERATION OF UP TO RM47,665,676.80 (“PROPOSED 70% ACQUISITION”); AND (II) PROPOSED GRANTING BY THE VENDORS OF A CALL OPTION FOR KOBAY TO ACQUIRE THE REMAINING 30% EQUITY INTEREST IN THE AVELON GROUP AND THE GRANTING BY KOBAY OF A PUT OPTION TO THE VENDORS TO SELL OR CAUSE TO SELL THE REMAINING 30% EQUITY INTEREST IN THE AVELON GROUP AFTER THE PROPOSED 70% ACQUISITION (“PROPOSED CALL AND PUT OPTION”) (THE PROPOSED 70% ACQUISITION AND PROPOSED CALL AND PUT OPTION ARE COLLECTIVELY REFERRED TO AS THE “PROPOSED ACQUISITION”) (III) PROPOSED DIVERSIFICATION OF THE EXISTING PRINCIPAL ACTIVITIES OF KOBAY AND ITS SUBSIDIARIES TO INCLUDE THE SALE AND/OR MANUFACTURING OF PHARMACEUTICAL AND HEALTHCARE PRODUCTS (“PROPOSED DIVERSIFICATION”) (THE PROPOSED ACQUISITION AND PROPOSED DIVERSIFICATION ARE COLLECTIVELY REFERRED TO AS THE “PROPOSALS”) AND NOTICE OF EXTRAORDINARY GENERAL MEETING
Attachments :
KOBAY – Circular 5 July 2021 (Part 1).pdf
KOBAY – Circular 5 July 2021 (Part 2).pdf
KOBAY – Circular 5 July 2021 (Part 3).pdf